Transaction in Own Shares

RNS Number : 8567U

Ingenta PLC

03 July 2024

3 July 2024

Ingenta plc

("Ingenta" or the "Company")

Transaction in own shares

The Company confirms that, pursuant to the authority granted at its 2023 Annual General Meeting, it has purchased, through Cavendish Capital Markets Limited, 25,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") for cancellation at a price of 114p per share.

Date of purchase:	2 July 2024
Number of Ordinary Shares purchased (aggregated volume):	25,000
Highest price paid per Ordinary Share (pence):	114
Lowest price paid per Ordinary Share (pence):	114
Volume weighted average price paid per share Ordinary Share (pence):	114
Volume weighted average price paid per share Ordinary Share (pence):	114

Following the cancellation of the Ordinary Shares, the Company's issued share capital will consist of 15,098,125 Ordinary Shares, of which 587,930 continue to be held in Treasury. Accordingly, the Company will have total voting rights of 14,510,195 following cancellation. This figure (14,510,195) represents the total voting rights in the Company which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules of the FCA.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, a detailed breakdown of individual trades is available below:

Number of shares purchased	Transaction price (pence per share)	Time of transaction	Venue
25,000	114	13:30:10	AIMX

For further information contact:

Ingenta Plc
Scott Winner, Jon Sheffield

+44 (0) 1865 397 800

Cavendish Capital Markets Limited

Katy Birkin, Callum Davidson

+44 (0) 20 7397 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSBUGDRCXGDGSD